Imaging bacterial infections
Nature Materials
2011년7월18일
A family of highly sensitive contrast agents that enable in vivo imaging of bacterial infections in rats is presented in a study published online this week in Nature Materials. Such contrast agents could aid in the early clinical detection of bacterial infections, which could help people to avoid medical complications such as tissue damage or sepsis.
Bacteria are an important cause of various illnesses and sometimes death worldwide. The main challenge in imaging bacterial infections is in developing contrast agents that enter bacteria specifically and quickly.
Niren Murthy and colleagues achieved this by chemically attaching a fluorescent side group, the part of the molecule that creates the imaging contrast, to a specific type of carbohydrates that plays an important role in the metabolism of many bacteria. The researchers found that Escherichia coli and other species rapidly take up these metabolic fluorescent imaging probes, and that infections could be imaged with 100-fold improved sensitivity compared with previous contrast agents.
doi: 10.1038/nmat3074
리서치 하이라이트
-
7월29일
Engineering: Just add water to activate a disposable paper batteryScientific Reports
-
7월26일
Physics: Slab avalanche origin similar to that of earthquakesNature Physics
-
7월13일
Planetary science: Origins of one of the oldest martian meteorites identifiedNature Communications
-
7월12일
Astronomy: Casualty risk from uncontrolled rocket re-entries assessedNature Astronomy
-
7월12일
Physics: Beam vibrations used to measure ‘big G’Nature Physics
-
7월6일
Biotechnology: Mice cloned from freeze-dried somatic cellsNature Communications